Bourne Lent Asset Management Inc Pacific Biosciences Of California, Inc. Transaction History
Bourne Lent Asset Management Inc
- $261 Million
- Q2 2024
A detailed history of Bourne Lent Asset Management Inc transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Bourne Lent Asset Management Inc holds 951,395 shares of PACB stock, worth $1.66 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
951,395
Previous 654,415
45.38%
Holding current value
$1.66 Million
Previous $2.45 Million
46.9%
% of portfolio
0.5%
Previous 0.99%
Shares
23 transactions
Others Institutions Holding PACB
# of Institutions
258Shares Held
234MCall Options Held
1.02MPut Options Held
965K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.2MShares$58.1 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA26MShares$45.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$41.3 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$40.9 Million5.63% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V816.7MShares$29.3 Million0.4% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $393M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...